| Luke Miller Lewis, MD | |
|
3535 Southern Blvd, Kettering, OH 45429-1221 | |
| (937) 395-8646 | |
| (937) 522-8100 |
| Full Name | Luke Miller Lewis |
|---|---|
| Gender | Male |
| Speciality | Radiology - Radiation Oncology |
| Location | 3535 Southern Blvd, Kettering, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083147474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 35.145466 (Ohio) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Alliance Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437125572 PECOS PAC ID: 0840104360 Enrollment ID: O20031118000529 |
News Archive
According to the Food and Drug Administration (FDA), in the U.S. there are no scientific grounds for the medical use of use of marijuana and the agency is highly critical of attempts by individual states to legalise it.
Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).
Newly published data confirm a non-invasive Respiratory Stress Response (RSR) can quickly and accurately measure the presence of significant coronary artery disease (sCAD), the leading cause of cardiovascular death worldwide. Patients in the study with sCAD had a lower RSR compared to patients without.
The results of a study conducted by Dr. Anick Bérard, Professor and Fonds de recherche du Québec - Santé Research Chair on Medications and Pregnancy, at the University of Montreal's Faculty of Pharmacy and the Ste-Justine University Hospital demonstrate that the use of nicotine patches or the drug Zyban has positive effects for the unborn child and allows pregnant women to stop smoking during and after pregnancy.
› Verified 8 days ago
| Entity Name | Kettering Independent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629387865 PECOS PAC ID: 3173710936 Enrollment ID: O20101207000425 |
News Archive
According to the Food and Drug Administration (FDA), in the U.S. there are no scientific grounds for the medical use of use of marijuana and the agency is highly critical of attempts by individual states to legalise it.
Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).
Newly published data confirm a non-invasive Respiratory Stress Response (RSR) can quickly and accurately measure the presence of significant coronary artery disease (sCAD), the leading cause of cardiovascular death worldwide. Patients in the study with sCAD had a lower RSR compared to patients without.
The results of a study conducted by Dr. Anick Bérard, Professor and Fonds de recherche du Québec - Santé Research Chair on Medications and Pregnancy, at the University of Montreal's Faculty of Pharmacy and the Ste-Justine University Hospital demonstrate that the use of nicotine patches or the drug Zyban has positive effects for the unborn child and allows pregnant women to stop smoking during and after pregnancy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Luke Miller Lewis, MD 1 Prestige Pl Ste 550, Miamisburg, OH 45342-6115 Ph: (937) 762-1310 | Luke Miller Lewis, MD 3535 Southern Blvd, Kettering, OH 45429-1221 Ph: (937) 395-8646 |
News Archive
According to the Food and Drug Administration (FDA), in the U.S. there are no scientific grounds for the medical use of use of marijuana and the agency is highly critical of attempts by individual states to legalise it.
Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).
Newly published data confirm a non-invasive Respiratory Stress Response (RSR) can quickly and accurately measure the presence of significant coronary artery disease (sCAD), the leading cause of cardiovascular death worldwide. Patients in the study with sCAD had a lower RSR compared to patients without.
The results of a study conducted by Dr. Anick Bérard, Professor and Fonds de recherche du Québec - Santé Research Chair on Medications and Pregnancy, at the University of Montreal's Faculty of Pharmacy and the Ste-Justine University Hospital demonstrate that the use of nicotine patches or the drug Zyban has positive effects for the unborn child and allows pregnant women to stop smoking during and after pregnancy.
› Verified 8 days ago
Michael Caccamo, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 540 Lincoln Park Blvd, Ste 130, Kettering, OH 45429 Phone: 937-297-6306 Fax: 937-299-6300 | |
Dr. Paul Kreinbrink, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-8646 Fax: 937-522-8100 | |
Jeffery L Nielson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1563 E Dorothy Ln, Kettering, OH 45429 Phone: 937-296-2853 | |
John K Bidwell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-296-7202 | |
Richard A Mckenzie, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-296-7202 | |
Donald Marger, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2632 Woodman Center Ct, Kettering, OH 45420 Phone: 937-293-2273 |